An Infantile Misrepresentation

Tylenol lawsuits continue

If you purchased Infants’ Tylenol any time from October 2014 to January 6, 2020, you may be entitled to a few bucks.  Johnson and Johnson received negative backlash following the infamous talcum powder dispute and the company remains under scrutiny due to misrepresented pill bottles.  According to this most recent lawsuit, Johnson and Johnson allegedly advertises on its packaging that their Infants’ Tylenol is specially manufactured to supply a safe dosage for infants.  On the contrary, the concentration of acetaminophen is 160 mg, the same level found in Johnson and Johnson’s Children’s Tylenol. Read more

Oklahoma Tackles the Opioid Epidemic

Alarming epidemic

Since 1999, over 700,000 people in the United States have died from drug overdoses.  In response to this seemingly uncontrollable epidemic, the state of Oklahoma is stepping up as one of the first states to hold pharmaceutical companies accountable. Earlier this week, a judge ruled that Johnson & Johnson must pay $572 million for their role in the overdose death count.  In 2017 alone, 68% of the 70,000 US overdoses were at the hands of an opioid.  This landmark case cites Oklahoma’s public nuisance law and the argument that Johnson & Johnson put people in harm by engaging in “false and misleading marketing of both their drugs and opioids.” The state of Oklahoma blames Johnson & Johnson for the influx of opioids in the state. Read more

Carcinogen Capsules May Cause Cancer

A dangerous pill

The FDA recently discovered that certain heart and blood pressure medications contain the carcinogen NDMA, which may lead to cancer. As a result, several lawsuits have been filed against drug manufacturers and distributors, including the maker of Valsartan, Zhejiang Huahai Pharmaceutical Co.  Many of the medications have since been recalled by the FDA.  While it is reportedly difficult to prove a direct correlation between the medications and cancer, a projected 2,000 personal injury cases may be filed within the next year.  The number of cancer patients who have taken these medications that contain NDMA is unknown. Read more

Prescribing a Possible Birth Defect

Worth the risk?

If a birth defect is a potential side effect, then morning sickness may be worth it.  Although not FDA approved to treat morning sickness, the manufacturer of Zofran, GlaxoSmithKline, encouraged doctors to prescribe this anti-nausea pill to expectant mothers.  In 2009, Zofran was the leading anti-nausea medication prescribed to pregnant women, however, women were not warned of the potential harm this drug could cause their unborn children.  The possible dangers of Zofran did not become known until children were born with birth defects, such as cleft palate, heart, mouth, and musculoskeletal defects, jaundice, club foot, and organ abnormalities.  Typically, Zofran is only used to treat nausea after surgery or chemotherapy.  As a result of so many cases of birth defects linked to Zofran use, many people have chosen to file mass tort lawsuits for compensation. Read more